Related Experiment Videos
Cardiovascular risk factors in type 2 diabetes: the role of hyperglycaemia
M Massi-Benedetti1, M O Federici
1Department of Internal Medicine, University of Perugia, Italy.
Insights
Type 2 diabetes accelerates atherosclerosis, leading to macrovascular complications. Improved blood sugar control is crucial for reducing cardiovascular risks and mortality in diabetic patients.
Area of Science:
- Cardiovascular Science
- Endocrinology
- Metabolic Disorders
Background:
- Macrovascular complications are a leading cause of morbidity and mortality in Type 2 diabetes mellitus (T2DM).
- Diabetes itself accelerates atherosclerosis, independent of other risk factors like dyslipidemia, hypertension, and obesity.
- Hyperglycemia, hyperinsulinemia, and insulin resistance are key contributors to diabetic macrovascular disease.
Purpose of the Study:
- To elucidate the mechanisms by which diabetes contributes to accelerated atherosclerosis.
- To highlight the role of hyperglycemia in endothelial dysfunction and arterial wall changes.
- To emphasize the importance of glycemic control in mitigating vascular complications.
Main Methods:
- Review of existing literature on the pathophysiology of diabetic macrovascular complications.
- Analysis of the molecular mechanisms, including oxidative stress and non-enzymatic glycation.
- Examination of the impact of hyperglycemia on endothelial function, coagulation, and lipid profiles.
Main Results:
- Hyperglycemia damages endothelium via MAPK, PKC, and NF-κB pathways, increasing ICAM-1.
- Increased vasoconstriction, smooth muscle cell proliferation, and intimal thickening are associated with hyperglycemia.
- Type 2 diabetes is linked to a pro-thrombotic state and atherogenic lipid abnormalities.
Conclusions:
- Oxidative stress and non-enzymatic glycation mediate diabetes-induced atherosclerosis.
- Undiagnosed or poorly controlled postprandial hyperglycemia significantly increases vascular risk.
- Improved glycemic control is essential for reducing macrovascular complications and cardiovascular mortality in Type 2 diabetes.
Abstract:
Macrovascular complications are the most important causes of morbidity, mortality and disability in people with Type 2 diabetes mellitus. Although other known risk factors for macrovascular disease (e.g. dyslipidaemia, hypertension, obesity) often co-exist, diabetes itself is an important risk factor for accelerated development of atherosclerosis. Hyperglycaemia, hyperinsulinaemia and insulin resistance may each play a major role in the onset and development of atherosclerotic disease, which causes arterial wall dysfunction, haematological disturbances and lipid abnormalities through two mechanisms: oxidative stress and non-enzymatic glycation. Hyperglycaemia induces damage to the endothelium through activation of mitogen-activated protein kinase, protein kinase C and transcription factor nuclear factor (NF)-kappaB and through increased levels of pro-adhesion proteins such as intracellular adhesion molecule (ICAM)-1. The arterial wall tone is shifted towards vasoconstriction by hyperglycaemia, which is also associated with vascular smooth muscle cell proliferation and increased intimal wall thickness. Alteration of the coagulation system towards thrombophilia is observed in Type 2 diabetes and a series of lipid abnormalities that facilitate the development of atherosclerosis is evident. In Type 2 diabetes, undiagnosed disease and unrecognized postprandial hyperglycaemia are becoming the most relevant issues in reducing the risk of vascular complications and cardiovascular mortality; improved glycaemic control may reduce the incidence of macrovascular complications.